Postoperative Anxiolytic and Analgesic Effects of Pregabalin in Vitreo-Retinal Surgery: A randomized double-blind study

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210117050057N1

Enrollment

Registered

2021-01-26

Start date

2021-02-01

Completion date

Unknown

Last updated

2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitreo-Retinal surgery. Elective retinal surgeries

Interventions

Intervention 1: Control group: Controlled (Placebo) group involved 28 patients who received placebo drugs as premedication. Intervention 2: Intervention group: Case (Pregabalin) group involved 30 pati

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients aged 18 and older Consented to participate in this study

Exclusion criteria

Exclusion criteria: Patients' refusal to regional anesthesia Patients more than 75 years old Pregnancy Breast-feeding women Bleeding tendency History of drug abuse Renal insufficiency Neurological or psychiatric disorders or allergy to the study medication Intake of narcotic analgesics, pregabalin or benzodiazepines, within 24hrs before the study

Design outcomes

Primary

Measure	Time frame
Postoperative Pain. Timepoint: Postoperatively. Method of measurement: Verbal analogue pain score (VAS).	—

Secondary

Measure	Time frame
Anxiety. Timepoint: Postoperatively. Method of measurement: Verbal anxiety score.;Analgesic consumption. Timepoint: Postoperatively. Method of measurement: Calculation of analgesics consumed.	—

Countries

Qatar

Contacts

Public ContactMOHAMED ORIBY

Faculty of Medicine, Tanta University

oraiby500@hotmail.com+20 3 3059056

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026